nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprepitant—CYP3A7-CYP3A51P—Simvastatin—atherosclerosis	0.0557	0.0809	CbGbCtD
Aprepitant—CYP3A7—Simvastatin—atherosclerosis	0.0557	0.0809	CbGbCtD
Aprepitant—CYP3A7—Lovastatin—atherosclerosis	0.0545	0.0792	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Lovastatin—atherosclerosis	0.0545	0.0792	CbGbCtD
Aprepitant—CYP3A5—Rosuvastatin—atherosclerosis	0.0449	0.0653	CbGbCtD
Aprepitant—CYP3A5—Simvastatin—atherosclerosis	0.0418	0.0607	CbGbCtD
Aprepitant—CYP3A5—Lovastatin—atherosclerosis	0.0409	0.0594	CbGbCtD
Aprepitant—CYP3A5—Pravastatin—atherosclerosis	0.0409	0.0594	CbGbCtD
Aprepitant—CYP2C19—Rosuvastatin—atherosclerosis	0.0363	0.0527	CbGbCtD
Aprepitant—CYP2C19—Simvastatin—atherosclerosis	0.0337	0.049	CbGbCtD
Aprepitant—CYP2C19—Lovastatin—atherosclerosis	0.033	0.0479	CbGbCtD
Aprepitant—CYP2C9—Rosuvastatin—atherosclerosis	0.0301	0.0438	CbGbCtD
Aprepitant—CYP2C9—Simvastatin—atherosclerosis	0.028	0.0407	CbGbCtD
Aprepitant—CYP2C9—Pravastatin—atherosclerosis	0.0274	0.0398	CbGbCtD
Aprepitant—CYP2C9—Lovastatin—atherosclerosis	0.0274	0.0398	CbGbCtD
Aprepitant—CYP3A4—Rosuvastatin—atherosclerosis	0.0175	0.0255	CbGbCtD
Aprepitant—CYP3A4—Ezetimibe—atherosclerosis	0.0175	0.0255	CbGbCtD
Aprepitant—CYP3A4—Simvastatin—atherosclerosis	0.0163	0.0237	CbGbCtD
Aprepitant—CYP3A4—Lovastatin—atherosclerosis	0.0159	0.0232	CbGbCtD
Aprepitant—CYP3A4—Pravastatin—atherosclerosis	0.0159	0.0232	CbGbCtD
Aprepitant—Mental disorder—Simvastatin—atherosclerosis	0.000423	0.00223	CcSEcCtD
Aprepitant—Tremor—Lovastatin—atherosclerosis	0.000421	0.00222	CcSEcCtD
Aprepitant—Erythema—Simvastatin—atherosclerosis	0.000421	0.00222	CcSEcCtD
Aprepitant—Ill-defined disorder—Lovastatin—atherosclerosis	0.000417	0.0022	CcSEcCtD
Aprepitant—Eye disorder—Niacin—atherosclerosis	0.000415	0.00219	CcSEcCtD
Aprepitant—Flatulence—Simvastatin—atherosclerosis	0.000415	0.00219	CcSEcCtD
Aprepitant—Tinnitus—Niacin—atherosclerosis	0.000414	0.00218	CcSEcCtD
Aprepitant—Erythema multiforme—Pravastatin—atherosclerosis	0.000413	0.00218	CcSEcCtD
Aprepitant—Dysgeusia—Simvastatin—atherosclerosis	0.000412	0.00217	CcSEcCtD
Aprepitant—Flushing—Niacin—atherosclerosis	0.000412	0.00217	CcSEcCtD
Aprepitant—Angioedema—Lovastatin—atherosclerosis	0.000411	0.00217	CcSEcCtD
Aprepitant—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000409	0.00216	CcSEcCtD
Aprepitant—Anaemia—Ezetimibe—atherosclerosis	0.000408	0.00215	CcSEcCtD
Aprepitant—Tinnitus—Pravastatin—atherosclerosis	0.000407	0.00215	CcSEcCtD
Aprepitant—Malaise—Lovastatin—atherosclerosis	0.000406	0.00214	CcSEcCtD
Aprepitant—Cardiac disorder—Pravastatin—atherosclerosis	0.000406	0.00214	CcSEcCtD
Aprepitant—Flushing—Pravastatin—atherosclerosis	0.000406	0.00214	CcSEcCtD
Aprepitant—Muscle spasms—Simvastatin—atherosclerosis	0.000405	0.00213	CcSEcCtD
Aprepitant—Angioedema—Ezetimibe—atherosclerosis	0.000403	0.00213	CcSEcCtD
Aprepitant—Angiopathy—Niacin—atherosclerosis	0.000403	0.00212	CcSEcCtD
Aprepitant—Chills—Niacin—atherosclerosis	0.000398	0.0021	CcSEcCtD
Aprepitant—Malaise—Ezetimibe—atherosclerosis	0.000398	0.0021	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000395	0.00208	CcSEcCtD
Aprepitant—Tremor—Simvastatin—atherosclerosis	0.000394	0.00208	CcSEcCtD
Aprepitant—Alopecia—Niacin—atherosclerosis	0.000392	0.00207	CcSEcCtD
Aprepitant—Chills—Pravastatin—atherosclerosis	0.000392	0.00207	CcSEcCtD
Aprepitant—Insomnia—Rosuvastatin—atherosclerosis	0.000392	0.00207	CcSEcCtD
Aprepitant—Ill-defined disorder—Simvastatin—atherosclerosis	0.00039	0.00206	CcSEcCtD
Aprepitant—Palpitations—Ezetimibe—atherosclerosis	0.00039	0.00206	CcSEcCtD
Aprepitant—Paraesthesia—Rosuvastatin—atherosclerosis	0.000389	0.00205	CcSEcCtD
Aprepitant—Anaemia—Simvastatin—atherosclerosis	0.000389	0.00205	CcSEcCtD
Aprepitant—Erythema—Niacin—atherosclerosis	0.000386	0.00204	CcSEcCtD
Aprepitant—Malnutrition—Niacin—atherosclerosis	0.000386	0.00204	CcSEcCtD
Aprepitant—Alopecia—Pravastatin—atherosclerosis	0.000386	0.00204	CcSEcCtD
Aprepitant—Cough—Ezetimibe—atherosclerosis	0.000385	0.00203	CcSEcCtD
Aprepitant—Angioedema—Simvastatin—atherosclerosis	0.000384	0.00203	CcSEcCtD
Aprepitant—Arthralgia—Lovastatin—atherosclerosis	0.000383	0.00202	CcSEcCtD
Aprepitant—Chest pain—Lovastatin—atherosclerosis	0.000383	0.00202	CcSEcCtD
Aprepitant—Myalgia—Lovastatin—atherosclerosis	0.000383	0.00202	CcSEcCtD
Aprepitant—Anxiety—Lovastatin—atherosclerosis	0.000382	0.00201	CcSEcCtD
Aprepitant—Dyspepsia—Rosuvastatin—atherosclerosis	0.000381	0.00201	CcSEcCtD
Aprepitant—Hypertension—Ezetimibe—atherosclerosis	0.000381	0.00201	CcSEcCtD
Aprepitant—Flatulence—Niacin—atherosclerosis	0.000381	0.00201	CcSEcCtD
Aprepitant—Malaise—Simvastatin—atherosclerosis	0.000379	0.002	CcSEcCtD
Aprepitant—Discomfort—Lovastatin—atherosclerosis	0.000378	0.002	CcSEcCtD
Aprepitant—Myalgia—Ezetimibe—atherosclerosis	0.000376	0.00198	CcSEcCtD
Aprepitant—Chest pain—Ezetimibe—atherosclerosis	0.000376	0.00198	CcSEcCtD
Aprepitant—Arthralgia—Ezetimibe—atherosclerosis	0.000376	0.00198	CcSEcCtD
Aprepitant—Flatulence—Pravastatin—atherosclerosis	0.000375	0.00198	CcSEcCtD
Aprepitant—Dry mouth—Lovastatin—atherosclerosis	0.000375	0.00198	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000373	0.00197	CcSEcCtD
Aprepitant—Dysgeusia—Pravastatin—atherosclerosis	0.000373	0.00196	CcSEcCtD
Aprepitant—Muscle spasms—Niacin—atherosclerosis	0.000371	0.00196	CcSEcCtD
Aprepitant—Discomfort—Ezetimibe—atherosclerosis	0.000371	0.00196	CcSEcCtD
Aprepitant—Pain—Rosuvastatin—atherosclerosis	0.00037	0.00195	CcSEcCtD
Aprepitant—Constipation—Rosuvastatin—atherosclerosis	0.00037	0.00195	CcSEcCtD
Aprepitant—Confusional state—Lovastatin—atherosclerosis	0.00037	0.00195	CcSEcCtD
Aprepitant—Dry mouth—Ezetimibe—atherosclerosis	0.000367	0.00194	CcSEcCtD
Aprepitant—Anaphylactic shock—Lovastatin—atherosclerosis	0.000367	0.00194	CcSEcCtD
Aprepitant—Muscle spasms—Pravastatin—atherosclerosis	0.000366	0.00193	CcSEcCtD
Aprepitant—Infection—Lovastatin—atherosclerosis	0.000365	0.00192	CcSEcCtD
Aprepitant—Confusional state—Ezetimibe—atherosclerosis	0.000363	0.00191	CcSEcCtD
Aprepitant—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00036	0.0019	CcSEcCtD
Aprepitant—Thrombocytopenia—Lovastatin—atherosclerosis	0.000359	0.0019	CcSEcCtD
Aprepitant—Arthralgia—Simvastatin—atherosclerosis	0.000358	0.00189	CcSEcCtD
Aprepitant—Chest pain—Simvastatin—atherosclerosis	0.000358	0.00189	CcSEcCtD
Aprepitant—Myalgia—Simvastatin—atherosclerosis	0.000358	0.00189	CcSEcCtD
Aprepitant—Infection—Ezetimibe—atherosclerosis	0.000358	0.00189	CcSEcCtD
Aprepitant—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000357	0.00188	CcSEcCtD
Aprepitant—Anxiety—Simvastatin—atherosclerosis	0.000357	0.00188	CcSEcCtD
Aprepitant—Tremor—Pravastatin—atherosclerosis	0.000356	0.00188	CcSEcCtD
Aprepitant—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000354	0.00187	CcSEcCtD
Aprepitant—Discomfort—Simvastatin—atherosclerosis	0.000354	0.00187	CcSEcCtD
Aprepitant—Nervous system disorder—Ezetimibe—atherosclerosis	0.000353	0.00186	CcSEcCtD
Aprepitant—Angioedema—Niacin—atherosclerosis	0.000353	0.00186	CcSEcCtD
Aprepitant—Ill-defined disorder—Pravastatin—atherosclerosis	0.000353	0.00186	CcSEcCtD
Aprepitant—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000353	0.00186	CcSEcCtD
Aprepitant—Anaemia—Pravastatin—atherosclerosis	0.000352	0.00185	CcSEcCtD
Aprepitant—Anorexia—Lovastatin—atherosclerosis	0.00035	0.00185	CcSEcCtD
Aprepitant—Skin disorder—Ezetimibe—atherosclerosis	0.00035	0.00184	CcSEcCtD
Aprepitant—Angioedema—Pravastatin—atherosclerosis	0.000348	0.00183	CcSEcCtD
Aprepitant—Syncope—Niacin—atherosclerosis	0.000346	0.00183	CcSEcCtD
Aprepitant—Confusional state—Simvastatin—atherosclerosis	0.000346	0.00183	CcSEcCtD
Aprepitant—Urticaria—Rosuvastatin—atherosclerosis	0.000344	0.00181	CcSEcCtD
Aprepitant—Anaphylactic shock—Simvastatin—atherosclerosis	0.000343	0.00181	CcSEcCtD
Aprepitant—Oedema—Simvastatin—atherosclerosis	0.000343	0.00181	CcSEcCtD
Aprepitant—Malaise—Pravastatin—atherosclerosis	0.000343	0.00181	CcSEcCtD
Aprepitant—Abdominal pain—Rosuvastatin—atherosclerosis	0.000342	0.00181	CcSEcCtD
Aprepitant—Palpitations—Niacin—atherosclerosis	0.000341	0.0018	CcSEcCtD
Aprepitant—Infection—Simvastatin—atherosclerosis	0.000341	0.0018	CcSEcCtD
Aprepitant—Loss of consciousness—Niacin—atherosclerosis	0.00034	0.00179	CcSEcCtD
Aprepitant—Cough—Niacin—atherosclerosis	0.000337	0.00178	CcSEcCtD
Aprepitant—Thrombocytopenia—Simvastatin—atherosclerosis	0.000336	0.00177	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000334	0.00176	CcSEcCtD
Aprepitant—Insomnia—Lovastatin—atherosclerosis	0.000332	0.00175	CcSEcCtD
Aprepitant—Cough—Pravastatin—atherosclerosis	0.000332	0.00175	CcSEcCtD
Aprepitant—Paraesthesia—Lovastatin—atherosclerosis	0.00033	0.00174	CcSEcCtD
Aprepitant—Myalgia—Niacin—atherosclerosis	0.000329	0.00173	CcSEcCtD
Aprepitant—Arthralgia—Niacin—atherosclerosis	0.000329	0.00173	CcSEcCtD
Aprepitant—Hypertension—Pravastatin—atherosclerosis	0.000328	0.00173	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000328	0.00173	CcSEcCtD
Aprepitant—Anorexia—Simvastatin—atherosclerosis	0.000327	0.00173	CcSEcCtD
Aprepitant—Dyspnoea—Lovastatin—atherosclerosis	0.000327	0.00173	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000327	0.00172	CcSEcCtD
Aprepitant—Insomnia—Ezetimibe—atherosclerosis	0.000326	0.00172	CcSEcCtD
Aprepitant—Myalgia—Pravastatin—atherosclerosis	0.000324	0.00171	CcSEcCtD
Aprepitant—Chest pain—Pravastatin—atherosclerosis	0.000324	0.00171	CcSEcCtD
Aprepitant—Arthralgia—Pravastatin—atherosclerosis	0.000324	0.00171	CcSEcCtD
Aprepitant—Paraesthesia—Ezetimibe—atherosclerosis	0.000323	0.00171	CcSEcCtD
Aprepitant—Dyspepsia—Lovastatin—atherosclerosis	0.000323	0.0017	CcSEcCtD
Aprepitant—Anxiety—Pravastatin—atherosclerosis	0.000323	0.0017	CcSEcCtD
Aprepitant—Dry mouth—Niacin—atherosclerosis	0.000322	0.0017	CcSEcCtD
Aprepitant—Dyspnoea—Ezetimibe—atherosclerosis	0.000321	0.00169	CcSEcCtD
Aprepitant—Discomfort—Pravastatin—atherosclerosis	0.00032	0.00169	CcSEcCtD
Aprepitant—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000319	0.00168	CcSEcCtD
Aprepitant—Decreased appetite—Lovastatin—atherosclerosis	0.000319	0.00168	CcSEcCtD
Aprepitant—Dyspepsia—Ezetimibe—atherosclerosis	0.000317	0.00167	CcSEcCtD
Aprepitant—Fatigue—Lovastatin—atherosclerosis	0.000317	0.00167	CcSEcCtD
Aprepitant—Anaphylactic shock—Niacin—atherosclerosis	0.000315	0.00166	CcSEcCtD
Aprepitant—Oedema—Niacin—atherosclerosis	0.000315	0.00166	CcSEcCtD
Aprepitant—Constipation—Lovastatin—atherosclerosis	0.000314	0.00166	CcSEcCtD
Aprepitant—Pain—Lovastatin—atherosclerosis	0.000314	0.00166	CcSEcCtD
Aprepitant—Confusional state—Pravastatin—atherosclerosis	0.000313	0.00165	CcSEcCtD
Aprepitant—Decreased appetite—Ezetimibe—atherosclerosis	0.000313	0.00165	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000313	0.00165	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000311	0.00164	CcSEcCtD
Aprepitant—Asthenia—Rosuvastatin—atherosclerosis	0.000311	0.00164	CcSEcCtD
Aprepitant—Insomnia—Simvastatin—atherosclerosis	0.000311	0.00164	CcSEcCtD
Aprepitant—Anaphylactic shock—Pravastatin—atherosclerosis	0.00031	0.00164	CcSEcCtD
Aprepitant—Oedema—Pravastatin—atherosclerosis	0.00031	0.00164	CcSEcCtD
Aprepitant—Fatigue—Ezetimibe—atherosclerosis	0.00031	0.00164	CcSEcCtD
Aprepitant—Shock—Niacin—atherosclerosis	0.00031	0.00164	CcSEcCtD
Aprepitant—Infection—Pravastatin—atherosclerosis	0.000308	0.00163	CcSEcCtD
Aprepitant—Paraesthesia—Simvastatin—atherosclerosis	0.000308	0.00163	CcSEcCtD
Aprepitant—Pain—Ezetimibe—atherosclerosis	0.000308	0.00162	CcSEcCtD
Aprepitant—Constipation—Ezetimibe—atherosclerosis	0.000308	0.00162	CcSEcCtD
Aprepitant—Tachycardia—Niacin—atherosclerosis	0.000308	0.00162	CcSEcCtD
Aprepitant—Pruritus—Rosuvastatin—atherosclerosis	0.000306	0.00162	CcSEcCtD
Aprepitant—Skin disorder—Niacin—atherosclerosis	0.000306	0.00162	CcSEcCtD
Aprepitant—Dyspnoea—Simvastatin—atherosclerosis	0.000306	0.00161	CcSEcCtD
Aprepitant—Hyperhidrosis—Niacin—atherosclerosis	0.000305	0.00161	CcSEcCtD
Aprepitant—Thrombocytopenia—Pravastatin—atherosclerosis	0.000304	0.0016	CcSEcCtD
Aprepitant—Feeling abnormal—Lovastatin—atherosclerosis	0.000303	0.0016	CcSEcCtD
Aprepitant—Dyspepsia—Simvastatin—atherosclerosis	0.000302	0.00159	CcSEcCtD
Aprepitant—Anorexia—Niacin—atherosclerosis	0.000301	0.00159	CcSEcCtD
Aprepitant—Gastrointestinal pain—Lovastatin—atherosclerosis	0.0003	0.00158	CcSEcCtD
Aprepitant—Hyperhidrosis—Pravastatin—atherosclerosis	0.0003	0.00158	CcSEcCtD
Aprepitant—Decreased appetite—Simvastatin—atherosclerosis	0.000299	0.00157	CcSEcCtD
Aprepitant—Feeling abnormal—Ezetimibe—atherosclerosis	0.000297	0.00156	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000296	0.00156	CcSEcCtD
Aprepitant—Diarrhoea—Rosuvastatin—atherosclerosis	0.000296	0.00156	CcSEcCtD
Aprepitant—Fatigue—Simvastatin—atherosclerosis	0.000296	0.00156	CcSEcCtD
Aprepitant—Anorexia—Pravastatin—atherosclerosis	0.000296	0.00156	CcSEcCtD
Aprepitant—Hypotension—Niacin—atherosclerosis	0.000295	0.00155	CcSEcCtD
Aprepitant—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000294	0.00155	CcSEcCtD
Aprepitant—Constipation—Simvastatin—atherosclerosis	0.000294	0.00155	CcSEcCtD
Aprepitant—Pain—Simvastatin—atherosclerosis	0.000294	0.00155	CcSEcCtD
Aprepitant—Urticaria—Lovastatin—atherosclerosis	0.000292	0.00154	CcSEcCtD
Aprepitant—Abdominal pain—Lovastatin—atherosclerosis	0.00029	0.00153	CcSEcCtD
Aprepitant—Body temperature increased—Lovastatin—atherosclerosis	0.00029	0.00153	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000287	0.00151	CcSEcCtD
Aprepitant—Dizziness—Rosuvastatin—atherosclerosis	0.000286	0.00151	CcSEcCtD
Aprepitant—Urticaria—Ezetimibe—atherosclerosis	0.000286	0.00151	CcSEcCtD
Aprepitant—Insomnia—Niacin—atherosclerosis	0.000285	0.0015	CcSEcCtD
Aprepitant—Abdominal pain—Ezetimibe—atherosclerosis	0.000285	0.0015	CcSEcCtD
Aprepitant—Body temperature increased—Ezetimibe—atherosclerosis	0.000285	0.0015	CcSEcCtD
Aprepitant—Paraesthesia—Niacin—atherosclerosis	0.000283	0.00149	CcSEcCtD
Aprepitant—Feeling abnormal—Simvastatin—atherosclerosis	0.000283	0.00149	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000283	0.00149	CcSEcCtD
Aprepitant—Dyspnoea—Niacin—atherosclerosis	0.000281	0.00148	CcSEcCtD
Aprepitant—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000281	0.00148	CcSEcCtD
Aprepitant—Insomnia—Pravastatin—atherosclerosis	0.000281	0.00148	CcSEcCtD
Aprepitant—Somnolence—Niacin—atherosclerosis	0.00028	0.00148	CcSEcCtD
Aprepitant—Paraesthesia—Pravastatin—atherosclerosis	0.000279	0.00147	CcSEcCtD
Aprepitant—Dyspepsia—Niacin—atherosclerosis	0.000278	0.00146	CcSEcCtD
Aprepitant—Dyspnoea—Pravastatin—atherosclerosis	0.000277	0.00146	CcSEcCtD
Aprepitant—Decreased appetite—Niacin—atherosclerosis	0.000274	0.00145	CcSEcCtD
Aprepitant—Dyspepsia—Pravastatin—atherosclerosis	0.000273	0.00144	CcSEcCtD
Aprepitant—Rash—Rosuvastatin—atherosclerosis	0.000273	0.00144	CcSEcCtD
Aprepitant—Dermatitis—Rosuvastatin—atherosclerosis	0.000273	0.00144	CcSEcCtD
Aprepitant—Urticaria—Simvastatin—atherosclerosis	0.000273	0.00144	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Niacin—atherosclerosis	0.000272	0.00144	CcSEcCtD
Aprepitant—Abdominal pain—Simvastatin—atherosclerosis	0.000271	0.00143	CcSEcCtD
Aprepitant—Body temperature increased—Simvastatin—atherosclerosis	0.000271	0.00143	CcSEcCtD
Aprepitant—Headache—Rosuvastatin—atherosclerosis	0.000271	0.00143	CcSEcCtD
Aprepitant—Hypersensitivity—Lovastatin—atherosclerosis	0.00027	0.00143	CcSEcCtD
Aprepitant—Decreased appetite—Pravastatin—atherosclerosis	0.00027	0.00142	CcSEcCtD
Aprepitant—Pain—Niacin—atherosclerosis	0.00027	0.00142	CcSEcCtD
Aprepitant—Fatigue—Pravastatin—atherosclerosis	0.000268	0.00141	CcSEcCtD
Aprepitant—Pain—Pravastatin—atherosclerosis	0.000265	0.0014	CcSEcCtD
Aprepitant—Constipation—Pravastatin—atherosclerosis	0.000265	0.0014	CcSEcCtD
Aprepitant—Hypersensitivity—Ezetimibe—atherosclerosis	0.000265	0.0014	CcSEcCtD
Aprepitant—Asthenia—Lovastatin—atherosclerosis	0.000263	0.00139	CcSEcCtD
Aprepitant—Pruritus—Lovastatin—atherosclerosis	0.00026	0.00137	CcSEcCtD
Aprepitant—Asthenia—Ezetimibe—atherosclerosis	0.000258	0.00136	CcSEcCtD
Aprepitant—Gastrointestinal pain—Niacin—atherosclerosis	0.000258	0.00136	CcSEcCtD
Aprepitant—Nausea—Rosuvastatin—atherosclerosis	0.000257	0.00136	CcSEcCtD
Aprepitant—Feeling abnormal—Pravastatin—atherosclerosis	0.000256	0.00135	CcSEcCtD
Aprepitant—Pruritus—Ezetimibe—atherosclerosis	0.000255	0.00134	CcSEcCtD
Aprepitant—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000254	0.00134	CcSEcCtD
Aprepitant—Hypersensitivity—Simvastatin—atherosclerosis	0.000253	0.00133	CcSEcCtD
Aprepitant—Diarrhoea—Lovastatin—atherosclerosis	0.000251	0.00132	CcSEcCtD
Aprepitant—Urticaria—Niacin—atherosclerosis	0.00025	0.00132	CcSEcCtD
Aprepitant—Body temperature increased—Niacin—atherosclerosis	0.000249	0.00131	CcSEcCtD
Aprepitant—Abdominal pain—Niacin—atherosclerosis	0.000249	0.00131	CcSEcCtD
Aprepitant—Urticaria—Pravastatin—atherosclerosis	0.000247	0.0013	CcSEcCtD
Aprepitant—Asthenia—Simvastatin—atherosclerosis	0.000246	0.0013	CcSEcCtD
Aprepitant—Diarrhoea—Ezetimibe—atherosclerosis	0.000246	0.0013	CcSEcCtD
Aprepitant—Abdominal pain—Pravastatin—atherosclerosis	0.000245	0.00129	CcSEcCtD
Aprepitant—Body temperature increased—Pravastatin—atherosclerosis	0.000245	0.00129	CcSEcCtD
Aprepitant—Pruritus—Simvastatin—atherosclerosis	0.000243	0.00128	CcSEcCtD
Aprepitant—Dizziness—Lovastatin—atherosclerosis	0.000243	0.00128	CcSEcCtD
Aprepitant—Dizziness—Ezetimibe—atherosclerosis	0.000238	0.00126	CcSEcCtD
Aprepitant—Diarrhoea—Simvastatin—atherosclerosis	0.000235	0.00124	CcSEcCtD
Aprepitant—Vomiting—Lovastatin—atherosclerosis	0.000233	0.00123	CcSEcCtD
Aprepitant—Hypersensitivity—Niacin—atherosclerosis	0.000232	0.00123	CcSEcCtD
Aprepitant—Rash—Lovastatin—atherosclerosis	0.000231	0.00122	CcSEcCtD
Aprepitant—Dermatitis—Lovastatin—atherosclerosis	0.000231	0.00122	CcSEcCtD
Aprepitant—Headache—Lovastatin—atherosclerosis	0.00023	0.00121	CcSEcCtD
Aprepitant—Vomiting—Ezetimibe—atherosclerosis	0.000229	0.00121	CcSEcCtD
Aprepitant—Hypersensitivity—Pravastatin—atherosclerosis	0.000229	0.00121	CcSEcCtD
Aprepitant—Dizziness—Simvastatin—atherosclerosis	0.000227	0.0012	CcSEcCtD
Aprepitant—Rash—Ezetimibe—atherosclerosis	0.000227	0.0012	CcSEcCtD
Aprepitant—Dermatitis—Ezetimibe—atherosclerosis	0.000227	0.0012	CcSEcCtD
Aprepitant—Asthenia—Niacin—atherosclerosis	0.000226	0.00119	CcSEcCtD
Aprepitant—Headache—Ezetimibe—atherosclerosis	0.000226	0.00119	CcSEcCtD
Aprepitant—Pruritus—Niacin—atherosclerosis	0.000223	0.00118	CcSEcCtD
Aprepitant—Asthenia—Pravastatin—atherosclerosis	0.000223	0.00117	CcSEcCtD
Aprepitant—Pruritus—Pravastatin—atherosclerosis	0.00022	0.00116	CcSEcCtD
Aprepitant—Vomiting—Simvastatin—atherosclerosis	0.000218	0.00115	CcSEcCtD
Aprepitant—Nausea—Lovastatin—atherosclerosis	0.000218	0.00115	CcSEcCtD
Aprepitant—Rash—Simvastatin—atherosclerosis	0.000217	0.00114	CcSEcCtD
Aprepitant—Dermatitis—Simvastatin—atherosclerosis	0.000216	0.00114	CcSEcCtD
Aprepitant—Diarrhoea—Niacin—atherosclerosis	0.000216	0.00114	CcSEcCtD
Aprepitant—Headache—Simvastatin—atherosclerosis	0.000215	0.00113	CcSEcCtD
Aprepitant—Nausea—Ezetimibe—atherosclerosis	0.000214	0.00113	CcSEcCtD
Aprepitant—Diarrhoea—Pravastatin—atherosclerosis	0.000212	0.00112	CcSEcCtD
Aprepitant—Dizziness—Niacin—atherosclerosis	0.000209	0.0011	CcSEcCtD
Aprepitant—Dizziness—Pravastatin—atherosclerosis	0.000205	0.00108	CcSEcCtD
Aprepitant—Nausea—Simvastatin—atherosclerosis	0.000204	0.00108	CcSEcCtD
Aprepitant—Vomiting—Niacin—atherosclerosis	0.0002	0.00106	CcSEcCtD
Aprepitant—Rash—Niacin—atherosclerosis	0.000199	0.00105	CcSEcCtD
Aprepitant—Dermatitis—Niacin—atherosclerosis	0.000199	0.00105	CcSEcCtD
Aprepitant—Headache—Niacin—atherosclerosis	0.000198	0.00104	CcSEcCtD
Aprepitant—Vomiting—Pravastatin—atherosclerosis	0.000197	0.00104	CcSEcCtD
Aprepitant—Rash—Pravastatin—atherosclerosis	0.000196	0.00103	CcSEcCtD
Aprepitant—Dermatitis—Pravastatin—atherosclerosis	0.000196	0.00103	CcSEcCtD
Aprepitant—Headache—Pravastatin—atherosclerosis	0.000194	0.00103	CcSEcCtD
Aprepitant—Nausea—Niacin—atherosclerosis	0.000187	0.000988	CcSEcCtD
Aprepitant—Nausea—Pravastatin—atherosclerosis	0.000184	0.000972	CcSEcCtD
Aprepitant—CYP2C19—Metabolism—ABCG5—atherosclerosis	1.65e-05	0.000135	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.64e-05	0.000135	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—NAMPT—atherosclerosis	1.64e-05	0.000135	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ABCG1—atherosclerosis	1.63e-05	0.000134	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—LIPC—atherosclerosis	1.63e-05	0.000134	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—APOC3—atherosclerosis	1.62e-05	0.000133	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MMP9—atherosclerosis	1.62e-05	0.000133	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—LDLR—atherosclerosis	1.61e-05	0.000132	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CYP27A1—atherosclerosis	1.6e-05	0.000131	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—NFKB1—atherosclerosis	1.6e-05	0.000131	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.6e-05	0.000131	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.6e-05	0.000131	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—LPA—atherosclerosis	1.59e-05	0.00013	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.58e-05	0.000129	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CETP—atherosclerosis	1.58e-05	0.000129	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MAPK8—atherosclerosis	1.57e-05	0.000129	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—AKT1—atherosclerosis	1.57e-05	0.000129	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—BGN—atherosclerosis	1.54e-05	0.000126	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.54e-05	0.000126	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—FABP4—atherosclerosis	1.54e-05	0.000126	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—LCAT—atherosclerosis	1.54e-05	0.000126	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.53e-05	0.000125	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—APOA5—atherosclerosis	1.52e-05	0.000125	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—APOA2—atherosclerosis	1.52e-05	0.000124	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	1.52e-05	0.000124	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ALOX15—atherosclerosis	1.52e-05	0.000124	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	1.52e-05	0.000124	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—SCARB1—atherosclerosis	1.51e-05	0.000124	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—APOA4—atherosclerosis	1.51e-05	0.000124	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—HMOX1—atherosclerosis	1.51e-05	0.000124	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ABCG5—atherosclerosis	1.5e-05	0.000123	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.5e-05	0.000123	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CYP7A1—atherosclerosis	1.48e-05	0.000121	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.48e-05	0.000121	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PLA2G1B—atherosclerosis	1.47e-05	0.00012	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—VEGFA—atherosclerosis	1.45e-05	0.000119	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.45e-05	0.000119	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—LPA—atherosclerosis	1.45e-05	0.000119	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—APOB—atherosclerosis	1.44e-05	0.000118	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—STAT3—atherosclerosis	1.44e-05	0.000118	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.44e-05	0.000118	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.43e-05	0.000117	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—HMGCR—atherosclerosis	1.43e-05	0.000117	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ALOX5—atherosclerosis	1.42e-05	0.000116	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.41e-05	0.000116	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GSTM1—atherosclerosis	1.41e-05	0.000115	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—BGN—atherosclerosis	1.4e-05	0.000115	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.39e-05	0.000114	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—APOA5—atherosclerosis	1.39e-05	0.000114	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—LPL—atherosclerosis	1.38e-05	0.000113	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MAPK3—atherosclerosis	1.37e-05	0.000113	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CYP27A1—atherosclerosis	1.37e-05	0.000112	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.35e-05	0.000111	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.35e-05	0.00011	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GPX1—atherosclerosis	1.35e-05	0.00011	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	1.34e-05	0.00011	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TGFB1—atherosclerosis	1.33e-05	0.000109	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.32e-05	0.000108	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.32e-05	0.000108	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.31e-05	0.000107	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CD36—atherosclerosis	1.31e-05	0.000107	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.31e-05	0.000107	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.31e-05	0.000107	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ALOX15—atherosclerosis	1.3e-05	0.000106	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	1.3e-05	0.000106	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	1.3e-05	0.000106	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—APOA2—atherosclerosis	1.3e-05	0.000106	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ALOX5—atherosclerosis	1.29e-05	0.000106	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ABCG5—atherosclerosis	1.28e-05	0.000105	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.28e-05	0.000105	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—NAMPT—atherosclerosis	1.27e-05	0.000104	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ABCA1—atherosclerosis	1.27e-05	0.000104	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.26e-05	0.000104	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—LIPC—atherosclerosis	1.26e-05	0.000103	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.26e-05	0.000103	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—APOC3—atherosclerosis	1.26e-05	0.000103	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—LDLR—atherosclerosis	1.25e-05	0.000102	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—MTHFR—atherosclerosis	1.24e-05	0.000102	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—LPA—atherosclerosis	1.24e-05	0.000101	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CETP—atherosclerosis	1.22e-05	9.98e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PPARA—atherosclerosis	1.22e-05	9.98e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—BGN—atherosclerosis	1.2e-05	9.83e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.19e-05	9.78e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.19e-05	9.76e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—APOA5—atherosclerosis	1.19e-05	9.73e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—LCAT—atherosclerosis	1.19e-05	9.72e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—FABP4—atherosclerosis	1.19e-05	9.72e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—AGT—atherosclerosis	1.18e-05	9.67e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—SCARB1—atherosclerosis	1.17e-05	9.56e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—APOA4—atherosclerosis	1.16e-05	9.54e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—NAMPT—atherosclerosis	1.16e-05	9.49e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—APOE—atherosclerosis	1.16e-05	9.47e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.15e-05	9.45e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.15e-05	9.44e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—LIPC—atherosclerosis	1.15e-05	9.43e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—CAV1—atherosclerosis	1.15e-05	9.38e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—APOC3—atherosclerosis	1.14e-05	9.38e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.14e-05	9.37e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	1.14e-05	9.37e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—APOA1—atherosclerosis	1.14e-05	9.36e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—LDLR—atherosclerosis	1.14e-05	9.32e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.14e-05	9.31e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.13e-05	9.26e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.12e-05	9.17e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.12e-05	9.15e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CETP—atherosclerosis	1.11e-05	9.1e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ALOX5—atherosclerosis	1.1e-05	9.04e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—HMGCR—atherosclerosis	1.1e-05	9.03e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—HMOX1—atherosclerosis	1.09e-05	8.93e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—SCARB1—atherosclerosis	1.06e-05	8.72e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.06e-05	8.66e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—APOB—atherosclerosis	1.04e-05	8.55e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PIK3CG—atherosclerosis	1.04e-05	8.55e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.04e-05	8.49e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.02e-05	8.36e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GSTM1—atherosclerosis	1.02e-05	8.32e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PPARG—atherosclerosis	1.01e-05	8.25e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IL6—atherosclerosis	1.01e-05	8.23e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—HMGCR—atherosclerosis	1e-05	8.23e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ALOX15—atherosclerosis	1e-05	8.21e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—APOA2—atherosclerosis	1e-05	8.21e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1e-05	8.21e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1e-05	8.21e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—LPL—atherosclerosis	9.97e-06	8.17e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	9.94e-06	8.14e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—NAMPT—atherosclerosis	9.9e-06	8.11e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ABCG5—atherosclerosis	9.9e-06	8.11e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—INS—atherosclerosis	9.88e-06	8.09e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	9.85e-06	8.07e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—LIPC—atherosclerosis	9.84e-06	8.06e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ABCA1—atherosclerosis	9.82e-06	8.05e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—APOC3—atherosclerosis	9.78e-06	8.01e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GPX1—atherosclerosis	9.73e-06	7.97e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—LDLR—atherosclerosis	9.72e-06	7.96e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—LPA—atherosclerosis	9.56e-06	7.83e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CETP—atherosclerosis	9.5e-06	7.78e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CD36—atherosclerosis	9.47e-06	7.76e-05	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—AKT1—atherosclerosis	9.27e-06	7.6e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—BGN—atherosclerosis	9.26e-06	7.58e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—APOA5—atherosclerosis	9.17e-06	7.51e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—SCARB1—atherosclerosis	9.09e-06	7.45e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	9.06e-06	7.42e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ALB—atherosclerosis	9.05e-06	7.42e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—MTHFR—atherosclerosis	8.98e-06	7.35e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ABCA1—atherosclerosis	8.96e-06	7.34e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	8.85e-06	7.25e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	8.82e-06	7.23e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PPARA—atherosclerosis	8.81e-06	7.21e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—NOS3—atherosclerosis	8.66e-06	7.09e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—HMGCR—atherosclerosis	8.59e-06	7.03e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—AGT—atherosclerosis	8.53e-06	6.99e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ALOX5—atherosclerosis	8.52e-06	6.98e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—HMOX1—atherosclerosis	8.43e-06	6.9e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—APOE—atherosclerosis	8.36e-06	6.85e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—CAV1—atherosclerosis	8.28e-06	6.78e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—APOA1—atherosclerosis	8.26e-06	6.77e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—APOB—atherosclerosis	8.07e-06	6.61e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PTGS2—atherosclerosis	7.92e-06	6.49e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GSTM1—atherosclerosis	7.85e-06	6.43e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	7.75e-06	6.34e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—LPL—atherosclerosis	7.71e-06	6.31e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—HMOX1—atherosclerosis	7.68e-06	6.29e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ABCA1—atherosclerosis	7.65e-06	6.27e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—NAMPT—atherosclerosis	7.64e-06	6.26e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—LIPC—atherosclerosis	7.6e-06	6.22e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—APOC3—atherosclerosis	7.55e-06	6.18e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PIK3CG—atherosclerosis	7.54e-06	6.18e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GPX1—atherosclerosis	7.52e-06	6.16e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—LDLR—atherosclerosis	7.5e-06	6.15e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—APOB—atherosclerosis	7.36e-06	6.03e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CETP—atherosclerosis	7.33e-06	6e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CD36—atherosclerosis	7.32e-06	6e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PPARG—atherosclerosis	7.28e-06	5.96e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GSTM1—atherosclerosis	7.16e-06	5.87e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—INS—atherosclerosis	7.14e-06	5.85e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—LPL—atherosclerosis	7.03e-06	5.76e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—SCARB1—atherosclerosis	7.02e-06	5.75e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—MTHFR—atherosclerosis	6.94e-06	5.68e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GPX1—atherosclerosis	6.86e-06	5.62e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PPARA—atherosclerosis	6.81e-06	5.58e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CD36—atherosclerosis	6.68e-06	5.47e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—HMGCR—atherosclerosis	6.63e-06	5.43e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—AGT—atherosclerosis	6.59e-06	5.4e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—HMOX1—atherosclerosis	6.57e-06	5.38e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ALB—atherosclerosis	6.55e-06	5.36e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—APOE—atherosclerosis	6.46e-06	5.29e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—CAV1—atherosclerosis	6.4e-06	5.24e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—APOA1—atherosclerosis	6.39e-06	5.23e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—MTHFR—atherosclerosis	6.33e-06	5.18e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—APOB—atherosclerosis	6.29e-06	5.15e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—NOS3—atherosclerosis	6.26e-06	5.13e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PPARA—atherosclerosis	6.21e-06	5.09e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GSTM1—atherosclerosis	6.12e-06	5.01e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—AGT—atherosclerosis	6.01e-06	4.93e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—LPL—atherosclerosis	6.01e-06	4.92e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ABCA1—atherosclerosis	5.91e-06	4.84e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—APOE—atherosclerosis	5.89e-06	4.83e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GPX1—atherosclerosis	5.86e-06	4.8e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—CAV1—atherosclerosis	5.84e-06	4.78e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PIK3CG—atherosclerosis	5.83e-06	4.78e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—APOA1—atherosclerosis	5.82e-06	4.77e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PTGS2—atherosclerosis	5.73e-06	4.69e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CD36—atherosclerosis	5.71e-06	4.67e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PPARG—atherosclerosis	5.63e-06	4.61e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—INS—atherosclerosis	5.52e-06	4.52e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—MTHFR—atherosclerosis	5.41e-06	4.43e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PIK3CG—atherosclerosis	5.32e-06	4.36e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PPARA—atherosclerosis	5.31e-06	4.35e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—AGT—atherosclerosis	5.14e-06	4.21e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PPARG—atherosclerosis	5.13e-06	4.2e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—HMOX1—atherosclerosis	5.07e-06	4.15e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ALB—atherosclerosis	5.06e-06	4.14e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—APOE—atherosclerosis	5.03e-06	4.12e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—INS—atherosclerosis	5.03e-06	4.12e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—CAV1—atherosclerosis	4.99e-06	4.09e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—APOA1—atherosclerosis	4.98e-06	4.08e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—APOB—atherosclerosis	4.85e-06	3.98e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—NOS3—atherosclerosis	4.84e-06	3.96e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GSTM1—atherosclerosis	4.72e-06	3.87e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—LPL—atherosclerosis	4.64e-06	3.8e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ALB—atherosclerosis	4.61e-06	3.78e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PIK3CG—atherosclerosis	4.54e-06	3.72e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GPX1—atherosclerosis	4.52e-06	3.7e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PTGS2—atherosclerosis	4.43e-06	3.63e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—NOS3—atherosclerosis	4.41e-06	3.62e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CD36—atherosclerosis	4.4e-06	3.61e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PPARG—atherosclerosis	4.38e-06	3.59e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—INS—atherosclerosis	4.3e-06	3.52e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—MTHFR—atherosclerosis	4.17e-06	3.42e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PPARA—atherosclerosis	4.09e-06	3.35e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PTGS2—atherosclerosis	4.04e-06	3.31e-05	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—AKT1—atherosclerosis	3.98e-06	3.26e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—AGT—atherosclerosis	3.97e-06	3.25e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ALB—atherosclerosis	3.94e-06	3.23e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—APOE—atherosclerosis	3.89e-06	3.18e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—CAV1—atherosclerosis	3.85e-06	3.15e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—APOA1—atherosclerosis	3.84e-06	3.15e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—NOS3—atherosclerosis	3.77e-06	3.09e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.51e-06	2.87e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PTGS2—atherosclerosis	3.45e-06	2.83e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PPARG—atherosclerosis	3.38e-06	2.77e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—INS—atherosclerosis	3.32e-06	2.72e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ALB—atherosclerosis	3.04e-06	2.49e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—NOS3—atherosclerosis	2.91e-06	2.38e-05	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—AKT1—atherosclerosis	2.88e-06	2.36e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.66e-06	2.18e-05	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—AKT1—atherosclerosis	2.23e-06	1.82e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—AKT1—atherosclerosis	2.03e-06	1.66e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—AKT1—atherosclerosis	1.73e-06	1.42e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—AKT1—atherosclerosis	1.34e-06	1.1e-05	CbGpPWpGaD
